The University of Chicago Header Logo

Connection

Seiko Diane Yamada to Benzimidazoles

Back to Details
This is a "connection" page, showing publications Seiko Diane Yamada has written about Benzimidazoles.
Seiko Diane Yamada
Connection Strength
0.102
Benzimidazoles
  1. Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study. Lancet Oncol. 2013 Feb; 14(2):134-40.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.